Skip to main content

Table 3 Remission rate of different diseases

From: Effect of CYP3 A4, CYP3 A5 and ABCB1 gene polymorphisms on the clinical efficacy of tacrolimus in the treatment of nephrotic syndrome

Disease types CR (cases) PR (cases) NR (cases) Total Effective rate (%)
MN 9 17 10 36 72.2
MsPGN 6 4 1 11 90.9
MCN 10 4 1 15 93.3
FSGS 0 0 5 5 0
SLE 5 16 5 26 80.7
HSPN 5 2 0 7 100
Total 35 43 22 100 78% (78/100)
  1. MN: membranous nephropathy; MsPGN: mesangial proliferative glomerulonephritis; MCN: minimal change nephropathy; FSGS: focal segmental glomerulosclerosis; SLE: systemic lupus erythematosus; HSPN: Henoch - Schonlein purpura nephritis;